Trials / Unknown
UnknownNCT04937894
Antibiotic Therapy for Infectious Diseases
The Efficacy and Safety of Tigecycline for the Treatment of Infectious Diseases
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Shandong University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- —
Summary
Tigecycline is a last-resort antibiotic that is used to treat severe infections caused by extensively drug-resistant bacteria. However, the efficacy and safety data for tigecycline in infectious patients are lacking. The aim of this study is to assess the efficacy and safety of tigecycline in infectious patients using pharmacokinetics and omics.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tigecycline | Efficacy and safety of Tigecycline |
Timeline
- Start date
- 2021-06-01
- Primary completion
- 2025-07-01
- Completion
- 2025-12-01
- First posted
- 2021-06-24
- Last updated
- 2021-06-24
Locations
1 site across 1 country: China
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04937894. Inclusion in this directory is not an endorsement.